Welcome to our dedicated page for Accenture Plc Ireland SEC filings (Ticker: ACN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Accenture plc (ACN) SEC filings page brings together the company’s official disclosures to the U.S. Securities and Exchange Commission, including annual and quarterly financial reports, proxy materials and current reports on significant events. As a New York Stock Exchange‑listed company incorporated in Ireland, Accenture uses these filings to provide detailed information on its financial performance, governance, strategy and material developments.
Accenture’s Form 8‑K current reports frequently furnish earnings releases for quarterly and annual periods, outlining revenues, operating margin, earnings per share, bookings, free cash flow and other key metrics. These 8‑K filings also describe the company’s use of non‑GAAP measures such as free cash flow, local‑currency growth and adjusted results that exclude specified business optimization costs, along with reconciliations to GAAP figures. Other 8‑K filings disclose leadership and organizational changes, including updates to Accenture’s growth model and senior management roles.
The company’s definitive proxy statement (DEF 14A) provides extensive detail on corporate governance, board structure, director nominees, executive compensation programs, share incentive plans and shareholder proposals. It also discusses Accenture’s strategy to be the reinvention partner of choice for clients, its Reinvention Services structure, and multi‑year trends in revenue growth, margins, earnings and cash returned to shareholders.
Through this page, users can access Accenture’s 10‑K annual reports, 10‑Q quarterly reports, 8‑K current reports, proxy statements and related exhibits as they are filed with the SEC’s EDGAR system. Stock Titan enhances these documents with AI‑powered summaries that highlight the main points of lengthy filings, explain non‑GAAP reconciliations, and surface items such as compensation plans and governance proposals. Investors tracking ACN can use these filings to review historical performance, understand management’s reporting practices and monitor material events affecting the company.
Accenture plc reported results from its 2026 annual general meeting. Shareholders approved an amended and restated 2010 Share Incentive Plan that authorizes an additional 7 million shares for issuance and extends the plan’s term until December 12, 2035.
Shareholders elected all nominated directors, approved on an advisory basis the compensation of named executive officers, and approved the amended share incentive plan. They also ratified KPMG LLP as independent auditor, authorized the Board to issue shares and opt out of pre-emption rights under Irish law, and set the price range for re-allotting treasury shares.
Accenture plc’s Chief Leadership & HR Officer, Katherine Lee Clifford, reported planned sales of company stock executed under a Rule 10b5-1 trading plan. On January 26, 2026, she sold several small blocks totaling 787 Class A ordinary shares at prices between about $276.62 and $283.25. After these transactions, she directly held 6,001 Class A shares and had an additional 27 shares reported as indirectly held by an immediate family member. The prices disclosed for some trades represent weighted average sale prices across multiple executions.
Accenture plc Chief Operating Officer Catherine Kiernan Hogan reported selling a total of 660 Class A ordinary shares on January 26, 2026 in a series of open market transactions under a pre-arranged Rule 10b5-1 trading plan. Sale prices ranged from about $277.45 to $283.25, with reported weighted-average prices for each trade. Following these sales, she directly owns 12,688 Class A shares and indirectly holds 2,048 shares through a family trust.
Accenture plc’s Chief Accounting Officer, Melissa A. Burgum, reported planned sales of Class A ordinary shares under a Rule 10b5-1 trading plan. On January 26, 2026, she executed several sale transactions at weighted average prices between about $278 and $282 per share.
Individual transactions included, for example, the sale of 2,161 Class A ordinary shares at $281.7589 per share. After the final reported transaction, she beneficially owned 8,179 Class A ordinary shares directly.
Accenture plc CEO-The Americas John F. Walsh reported planned insider stock sales under a Rule 10b5-1 trading plan. On January 27, 2026, he sold several blocks of Accenture Class A ordinary shares at weighted average prices between
All transactions were direct sales of non-derivative shares. After these trades, Walsh beneficially owned 27,221 Class A ordinary shares directly. The filing notes that each price represents a weighted average from multiple trades within the stated price ranges.
A holder of Class A Ordinary shares has filed a Form 144 notice to potentially sell up to 3,986 shares through UBS Financial Services on the NYSE. The filing lists an aggregate market value of
The person on whose behalf the shares may be sold represents that they are not aware of any material adverse, non‑public information about the issuer’s current or prospective operations, consistent with Rule 144 requirements.
Accenture plc’s general counsel and corporate secretary Joel Unruch reported selling a total of 1,026 Class A ordinary shares on January 23, 2026 in four open-market transactions under a pre-arranged Rule 10b5-1 trading plan. The sales were executed at weighted average prices of $280.217, $281.5664, $282.443, and $283.6871 per share, with underlying trades occurring in ranges from $279.83 to $284.34.
Following these planned sales, Unruch beneficially owns 27,181 Class A ordinary shares of Accenture in direct ownership.
Accenture has a shareholder filing a Rule 144 notice to sell 3,588 Class A ordinary shares through UBS Financial Services on the NYSE. The planned sale has an aggregate market value of $1,016,301.00 with an approximate sale date of January 26, 2026. The shares were acquired from the issuer as stock awards on January 1, 2026 and January 5, 2026, in amounts of 3,224 and 364 shares, respectively. Class A ordinary shares outstanding were 660,432,542, providing context for the size of this planned sale.
A holder of Class A Ordinary shares of ACN has filed a notice to sell 787 shares through UBS Financial Services, Inc. on the NYSE. The filing lists an aggregate market value of 222,915.75 for these shares and states that 660,432,542 shares of this class were outstanding at the time of the notice.
The shares to be sold come from recent stock awards from the issuer, including 530 shares acquired on 01/01/2026 and 257 shares acquired on 01/05/2026. The filer also sold 681 Class A Ordinary shares on 01/20/2026 for 191,107.80 over the prior three months, indicating ongoing, relatively small-scale personal share transactions.
Accenture plc has a shareholder planning to sell 660 Class A ordinary shares on or about 01/26/2026 through UBS Financial Services on the NYSE. The filing lists an aggregate market value of $186,945.00 for these shares, compared with 660,432,542 Class A ordinary shares outstanding. The shares to be sold were originally acquired from the issuer as stock awards, including 61 shares granted on 01/05/2025 and 599 shares granted on 10/18/2023, both recorded as non-cash awards.